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Introduction: Irritable bowel syndrome (IBS) is very common [252_TD$DIFF]disorder, with various associated symptoms
and affects quality of life. Alternatives to Western medication are often sought. Previous research has
suggested that Yoga practice could have a positive impact on alleviating these symptoms. The aimwas to
evaluate a comprehensive Remedial Yoga Module (RYM) for use as an intervention for IBS.
Methods: IBS patients (diagnosed according to Rome III criteria) were randomized into 3 groups[253_TD$DIFF]:
Yoga + limited conventional treatment, Combination (Yoga + conventional treatment[254_TD$DIFF]) and Wait-list
Control groups. Yoga and Combination groups received RYM sessions, three times a week, for 12 weeks,
and [255_TD$DIFF]theWait-list Control groupmaintained their current lifestyle. Primary endpoints were IBS-Symptom
Severity Scales (IBS-SSS) and IBS Quality of Life (IBS-QOL). Secondary endpoints were Hospital Anxiety
and Depression [310_TD$DIFF]Scale (HADS), Autonomic Symptom Score (ASS), IBS Global Assessment of Improvement
(IBS-GAI), Medicine and Supplement Use, physical ﬂexibility, and autonomic functions.
Results: 97 patients were randomized and 78 patients completed the study with high adherence (90%) to
RYM sessions. There were signiﬁcant improvements in IBS-SSS and IBS-QOL scores in Yoga (n =25;
p<0.001) and Combination groups (n =26; p<0.001)when compared toWait [249_TD$DIFF]-list Control group (n =27).
Also, HADS, ASS, IBS-GAI, physicalﬂexibility, and autonomic functionswere signiﬁcantly improved [256_TD$DIFF]which
correlatedwith a reduction in the amount of Medicine and Supplement Use in the Yoga and Combination
groups.
Conclusion: A 12-week RYM intervention could be a feasible stand-alone treatment or an integrative
option within conventional treatment for IBS patients with addressing IBS and associated conditions.
ã 2015 The Authors. Published by Elsevier GmbH. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).ivekananda Yoga Research
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Irritable bowel syndrome (IBS) is the most prevalent functional
gastrointestinal (GI) disorder in which patients experience
abdominal pain or discomfort that occurs in association with
altered bowel habits over a period of at least three months, in the
absence of any detectable organic cause [1,2]. IBS is classiﬁed as
either diarrhea predominant (IBS-D), constipation predominant
(IBS-C), or alternating stool pattern of mixed diarrhea and
constipation (IBS-M) [3]. The incidence rates range from 9 to [257_TD$DIFF]
23% worldwide and 10–15% in the USA [4]. Though the primary
cause and effect are not established, these patients suffer from a
host of secondary symptoms such as depression, anxiety, head-
aches, ﬁbromyalgia, migraines, and chronic fatigue syndrome [5,6].
Also, the quality of life (QOL) is affected to a greater extent in IBS
patients compared to organic GI disorders [7]. Stress impacts therticle under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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the development and exacerbation of IBS [8]. Autonomic imbal-
ance, either sympathetic excess or parasympathetic dominance,
was found in IBS patients [9,10].
IBS in the United States is estimated to cost more than $20
billion annually, in direct and indirect [258_TD$DIFF]expenditures [11,12]. The
pharmacological treatment options address targeted-symptomatic
relief and most of these treatments have side effects such as [311_TD$DIFF]
nausea, headaches, dry mouth, cramping, constipation, blurred
vision [312_TD$DIFF]. Thus, these patients remain inadequately treated and
dissatisﬁed with their QOL. About 50% of IBS patients often seek
alternative treatments like, probiotics, Chinese herbal therapy,
Yoga, acupuncture[260_TD$DIFF], and hypnosis [13]. Recent reviews on
complementary and alternative medicine (CAM) on IBS have all
concurred [261_TD$DIFF]that various CAM modalities could beneﬁt IBS patients
in improving their symptoms and QOL [13–15].
Yoga has been shown to improve headaches, anxiety, depres-
sion, chronic fatigue, and ﬁbromyalgia [16–20]. In a report of IBS
and current treatment options, Ducrotte had suggested that Yoga
postures targeting the lower abdomen would help in relieving the
symptoms of IBS by enhancing energy circulation in and around
the intestines [21].
Only four studies (3 on adolescents and 1 on adults) have
previously explored the effects of Yoga postures on IBS patients.
Even though, all these studies reported improvements in the Yoga
group, the regimens of Yoga practices, and durations of the
intervention varied. The sequence of the postures or the length of
time involved in each posture was not mentioned in detail. Two of
the studies had supervised instruction, and two others were self-
instructed [22–25]. There are few other studies that investigated
meditation in IBS patients [26–28].
In the present randomized trial, a comprehensive Remedial
Yoga Module (RYM) as an intervention for IBS was assessed. The
Yoga module importantly included all primary facets of Yoga,
body-breath-mind (postures, regulated breathing [262_TD$DIFF], andmeditation)
to be practiced three times a week, supervised by an instructor
[29]. The study investigated the efﬁcacy of RYM on IBS-Symptom
Severity Scales (IBS-SSS) and IBS-QOL. The secondary objectives
were to evaluate the impact of RYM on psychological symptoms,
autonomic nervous system function, and physical ﬂexibility.
2. Materials and methods
2.1. Subjects
The principal recruitment strategy was to publicize the clinical
trial to all gastroenterology clinics, primary care physicians[263_TD$DIFF], and
psychiatry ofﬁces around White Memorial Medical Center, Los
Angeles, California, USA. It was calculated that a total of 75 subjects
would be needed for the study. Assuming 30% attrition, it wasTable 1
Mean and median age and weight of randomized subjects.
Groups Total enrolled/female/male Age in ye
Yoga 33/31/2 44.061
44.061
45.801
Combination 33/28/5 44.271
44.271
41.1812
[248_TD$DIFF]Wait-list Control 31/25/6 45.081
44.071
45.771planned that 99 subjects should be enrolled into the study. Ethical
approval was obtained prior to the commencement of the trial.
A total of 120 patients were referred to the study from the
physicians’ ofﬁces in Los Angeles, California, USA. All male and
female subjects [264_TD$DIFF]from the ages of 18 years and above with a
diagnosis of IBS using Rome III criteria were considered eligible.
The inclusion criteriawere (i) patients that did not practice Yoga in
the last 6 months, (ii) not enrolled in any other alternative
medicine programs and (iii) patients committed to threemonths of
Yoga, three times a week. The exclusion criteria were (i) patients
with pregnancy, (ii) physical or mental disability to do Yoga, (iii)
history of drug, alcohol, or chemical abusewithin 6months prior to
screening, (iv) patients with any organic bowel disease, and (v)
inability to comply with study and follow-up procedures.
2.2. Study design
All subjects upon signing an informed consent form were
randomized (parallel) into three groups—Yoga group (Yoga
intervention with limited conventional treatment of three days
a week), Combination group (Yoga intervention and Conventional
Treatment), and Wait[249_TD$DIFF]-list Control group (current care and
lifestyle), and the allocation was 1:1:1. The Yoga group and [265_TD$DIFF]
Combination group were planned to differentiate between the
effects of Yoga alone and Yoga with medication on IBS symptoms.
All three groupswere assessed at three time points, atWeek 0 (Pre-
intervention), at Week 6 (Mid-intervention) and [266_TD$DIFF]at Week 12 (Post-
intervention), which would allow us to determine the ideal
duration of Yoga intervention required for IBS patients.
2.3. Randomization
In order to ensure allocation of an equal number of patients to
all three groups, randomization was carried out in blocks of six
patients, and the patients were asked to pull out numbers from an
envelope [30]. The random numbers were generated using online
software by a research team member not involved with data
collection [31]. The randomization process was concealed from
research team that was collecting data and the outcome assessors.
Ninety seven patients, both male (n =13; median age 46 years;
median weight 157 pounds) and female (n =84; median age, 45
years; median weight 157 pounds), meeting the inclusion and
exclusion criteria, were enrolled in the study between September
2012 and June 2014. Data collection was from November 2012 to
September 2014.
2.4. Interventioni)ars/w
3.42
3.42
2.71/
3.59/
3.59/
.75/
3.28/
3.68
2.88/Yoga group. Interventionwith RYM for IBS, one hour long [313_TD$DIFF]three
days a week for 12 weeks, was provided under the guidance ofeight in lbs (Mean SD) Median age in years/weight in lbs
/155.4826.39 45/156
/155.4826.39 45/156
159.0029.95 42/147
159.3629.88 46/157
159.3629.88 46/157
159.6834.62 42.5/155
168.6131.00 46/165
/169.7732.65 46/165
167.7331.52 46/164
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voluntarily reduce their medications (prescription and supple-
ment use if any) for IBS to three days a week. There was a
gastroenterologist available in case of aggravated symptoms
due to reduction in the medications. Patients were excluded
from analysis but not from attending Yoga sessions if theywere
using medication more than three times a week.ii) Combination group. Patients continuedwith theirmedications[267_TD
$DIFF], if any, under the guidance of their physician, and attended
Yoga classes three times a week for 12 weeks along with the
Yoga group.iii) Wait[249_TD$DIFF]-list control group. Patients continued their medications
if any, under the guidance of their physician, and were
suggested to maintain their lifestyle. The research staff had
advised [268_TD$DIFF]these controls to walk for 60min three times a
week during their waiting period of 12 weeks. The [269_TD$DIFF]Wait-list
Controls were contacted and were reminded one week
before their next assessment interval at Week 6 and 12. After
12 weeks of waiting, [270_TD$DIFF]they were offered the same Yoga
intervention. Themean andmedian age, andweight of patients
[271_TD$DIFF]as a result of randomization into the three groups is given in
Table 1.e 2
ocol of one hour [309_TD$DIFF]Remedial Yoga Module used for IBS.
me of Yoga practice Number of rounds
arting afﬁrmation (A-U-M, sound three times, OM, three times)
eathing practices
Hands-stretch breathing
Vyaghrasana/tiger pose breathing
Shashankasana/moon pose breath
Padottanasana/straight leg raise b
vaasana/instant relaxation
hilikarana Vyayama/loosening exercises
Forward and backward bending
Side bending
Twisting
Pavanamuktasana Kriya/wind reli
vaasana/quick relaxation
anas/postures-standing, sitting, prone, supine
Ardhakati cakrasana/half-waist wh
Ardha cakrasana/Half wheel pose
Padahastasana/hands to feet pose
Trikonasana/triangle pose
Parivritta trikonasana/revolved tri
Vrikshasana/tree pose
Vakrasana/half spinal twist
Pascimottanasana/seated forward
Bhujangasana/cobra pose
Shalabhasana/locust pose
Sarvangasana/shoulder stand
Viparitakaraniwith wall support/l
Matsyasana/ﬁsh pose
vaasana/deep relaxation
iyas/cleansing and Pranayama/regulated
breathing
Uddiyana Bandha and Agnisara/ab
abdomen
Kapalabhati/forceful exhalation
Vibhagiya Svasana/sectional breat
NadiShuddhi pranayama/alternate
Sitali/cooling pranayama
Sitkari/cooling pranayama
Bhramari/M-chanting
yana/meditation
Nadanusandhana/Yoga of sound
(A-U-M)
OM meditation (OM)
osing afﬁrmation—OM three times 1min
—Three positions of hand stretch; 5 + 52—5 rounds each clock wise and anti clo2.5. Yoga sessions
Six certiﬁed Yoga instructors were trained, instructed[272_TD$DIFF], and
monitored by the lead Yoga instructor and overseen by study
principal investigator. This was to ensure that the module was
followed exactly and [273_TD$DIFF]that there were no differences in the
intervention received by the patients from different Yoga
instructors. The Yoga instructors were concealed to the group
allocation of the patients. The Yoga session for the intervention
was followed as listed in Table 2 and as depicted in Supplementary
Fig. 1.
Each [314_TD$DIFF]one hour Yoga session had a gradual space and started
with simple breathing practices, loosening practices [315_TD$DIFF], and simple
postures with relaxation [316_TD$DIFF]in between. The session ended with
regulated breathing and meditation. Occasionally the sessions
lasted an extra 5–10min as some new patients required more
attention. The Yoga sessions were held three days a week
(evening) and one weekend morning class, which served as an
alternate option/makeup class. Adherence to the Yoga module
was monitored by research staff regularly, and there were no
deviations noted from the protocol. All patients received free Yoga
mats. A remuneration of $20 was paid to [276_TD$DIFF]Wait-list Controls forDuration (minutes)
2min
5min
53 2min
5 1min
ing 5 1min
reathing (supine position, both legs) 5 1min
2min
6min
20 2min
10 1min
10 1min
eving pose with leg rotation 5+52 2min
3min
18min
eel pose 1 + 1 2min
1 1min
1 1min
1+1 2min
angle pose 1 + 1 2min
1+1 2min
1+1 2min
bend pose 1 1min
1 1min
1 1min
1 1min
egs up the wall 1 1min
1 1min
6min
11min
dominal lock and rigorous movement of 3 (30 count) 2min
1 (60 count) 1min
hing 5 1min
nostril breathing 9 3min
5 1min
5 1min
5 1min
6min
9 3min
9 3min
ck wise each leg; 1 + 1—on both sides.
598 V. Kavuri et al. / European Journal of Integrative Medicine 7 (2015) 595–608attending each measurement, and Yoga and Combination groups
were paid $5 for the same. All the Yoga sessions and appraisals
were held in the research center [277_TD$DIFF](in a temperature and noise
controlled suite) of White Memorial Medical Center, Los Angeles,
USA.
2.6. Primary outcome assessments
2.6.1. Irritable Bowel Syndrome-Severity Scoring System (IBS-SSS)
IBS-SSS is a self-reported questionnaire regarding pain severity,
frequency, abdominal distension/bloating, bowel habit satisfac-
tion, and interference in life. The score for each of the questions
ranged from 0 to 100 with a visual analog scale. The total scorewas
500 points. A reduction of 50 points was considered to be adequate
for clinical improvement [32].
2.6.2. Irritable Bowel Syndrome Quality of Life (IBS-QOL)
IBS-QOL is a self-reported tool designed to assess various
aspects of quality of life in IBS patients. The questionnaire
consisted of a 5 point rating of 34 items inquiring into the
emotional well-being and interference with activity, body image,
health worry, food avoidance, social reaction, sex, and relation-
ships. The scores (reverse scoring) ranged from 34 to 170, with,
higher score indicating better quality of life. An increment of 14
points (when transformed to 0–100 range) was considered to be
clinically signiﬁcant improvement [33].
2.7. Secondary outcome assessments
2.7.1. Hospital Anxiety and Depression Scale (HADS)
Hospital Anxiety and Depression Scale is a 14 item self-
reported questionnaire, 7 items for anxiety and 7 items for
depression. This questionnaire used a 4 point rating (0–3) and
was divided into two subscales. Each subscale score ranged from 0
to 21 [278_TD$DIFF]– scores of 0–7 indicate normal levels [279_TD$DIFF], 8–10 indicate
borderline [280_TD$DIFF], and 11–21 suggest abnormal levels of anxiety and
depression [34].
2.7.2. IBS-Global Assessment of Improvement Score (IBS-GAI)
Patients were asked to provide a global assessment of their IBS
at 0, 6, and 12 weeks using the question, “Compared with your IBS
symptoms six weeks ago, are you now: terrible, worse, slightly
worse, no change, slightly better, better or excellent”. Minimum
scorewas 1 (terrible) andmaximum scorewas 7 (excellent), higher
score meaning improvement [35].
2.7.3. Autonomic Symptom Score
Autonomic Symptom Score is a 10 item self-reported scale, with
a score of 1 for presence and 0 for absence. Maximum score was 10
and minimum was 0 [25].
2.7.4. Medicine and supplement use
Subjects were interviewed about use of IBS symptom relieving
medications: prescription, non-prescription, herbal or dietary
supplements and were recorded at week 0. Changes in the drug
consumption from baseline were evaluated at week 6 and at week
12. If the subject changed a drug regimen that was equivalent to
baseline drug regimen with respect to medication class and/or
dosing period, and expected to yield a similar response, the drug
usagewas considered unchanged. Changing the dosage or stopping
one or more components of multiple drug regimens was also
considered alteration in drug usage. Final outcomes were
measured in frequency intervals of success (decrease in dosage
or cessation of medication) and failure (no change or increase in
dosage) [36].[317_TD$DIFF]2.8. Autonomic function testing
To assess sympathetic and parasympathetic reactivity before
and after intervention in the present study, a battery of four
cardiovascular reﬂex tests (two sympathetic tasks and two
parasympathetic tasks) were conducted. Electrocardiogram
(ECG) and respiration were acquired with a two channel Biopac
MP 45 Data Acquisition System, (BIOPAC, CA, USA). An automatic
blood pressure apparatus and hand grip dynamometer were used
in sympathetic reactivity tests [37].
[318_TD$DIFF]2.9. Sympathetic reactivity tests
[319_TD$DIFF]2.9.1. Handgrip test
Changes in diastolic blood pressure while undergoing handgrip
test [281_TD$DIFF]measured the sympathetic reactivity [37]. An electronic hand
grip dynamometer (Camry EH 101, Guangdong, China) and a
noninvasive automatic blood pressure monitor (Omron HEM 7121,
Kyoto, Japan) were used for this isometric test. The subjects were
directed to grip the hand-grip dynamometer with their dominant
hand and contract to the maximum extent possible for ﬁve
seconds. Themaximum reading (in lbs)was taken as themaximum
volumetric contraction (MVC). The subject was then asked to
contract the dynamometer continually at 30% of theMVC for 4min.
The changes in diastolic blood pressure were measured in the
contra lateral arm at 1, 2, and 4min.
[320_TD$DIFF] .9.2. Mental arithmetic test
A ﬁve minute mental arithmetic test was used to induce
cognitive stress and elicit sympathetic reactivity [37]. Subjects
were given a three digit number and asked to perform serial
subtraction using number 7 or 3. Subjects answered verbally, and
in case of a wrong answer, error message was given before a new
numberwas read. The heart ratewasmonitored bycontinuous ECG
and blood pressure was monitored by automatic blood pressure
machine at 1, 2, and 5min of the test.
[321_TD$DIFF] .10. Parasympathetic reactivity tests
[322_TD$DIFF] .10.1. Heart-rate variability in deep breathing test
The deep breathing was conducted with the patient resting in [282_TD$DIFF]
the supine position for 5min, connected to the standard
electrocardiogram (ECG) leads [37]. Before beginning the test,
patients were taught to breathe at a rate of 6 respiration cycles per
one minute. The ECG was recorded at a speed of 25mm/s for 180 s
while the patient breathed as instructed. Heart Rate Variabilitywas
extracted using the Kubios (version 2.2, Finland) software.
[323_TD$DIFF] .10.2. 30–ratio (Supine to upright position).
Using the body’s physiological response upon moving from a
supine to an upright posture, parasympathetic measurements
were obtained [37]. The “30–15” ratio was used to provide a
measure of vagus nerve function. The patients were asked to
remain in supine position for 5min (until their heart rate has
stabilized), and thenwere instructed tomove from the supine to an
upright posture. From the continuous ECG recording, after the
patient has stabilized in the upright posture, the R–R interval at
30th beat and 15th beat was obtained, and the “30–15” ratio was
calculated.
[324_TD$DIFF] .11. Measurements
2.11.1. Weight and height
Weight was measured to the nearest 0.1 lb (Detecto FH 133/11/
CH, Webb city, Missouri) and height was measured with a Seca
stadiometer (Seca 222, Chino, CA) to the nearest 0.1 inches (in.).
V. Kavuri et al. / European Journal of Integrative Medicine 7 (2015) 595–608 599BodyMass Index (BMI) was calculated using a BMI calculator (Seca
491, Chino, CA).
[325_TD$DIFF] .11.2. Hip and trunk ﬂexibility
Hip and trunk ﬂexibility was measured with a sit and reach box
(Baseline Corporation, Golden, Colorado) [38]. Patient was asked to
sit on the ﬂoor, shoes off and legs stretched with soles of the feet
against the sit and reach box, [283_TD$DIFF]with back straight. The subject was
then asked to place one hand over the other on themeasuring stick
(stretch indicator), and with knees straight, reach as far as possible
by moving the measuring stick. Best of three tries was recorded to
the nearest 0.1 cm.
[326_TD$DIFF] .11.3. Shoulder ﬂexibility
Flexibility of both shoulders was measured with a standard
goniometer (Baseline corp., Golden, Colorado) in centimeters (cm)
[39]. The patient was asked to stand straight, raise their right hand
over the shoulder and reach down their back as far as possible
while the left hand reached up the middle of the back behind the
waist, trying to bring ﬁngers of both hands together. The distance[(Fig._1)TD$FIG]
27 completed Week 6
(Mid assessment)
29 completed
(Mid assess
3 lost to post-asse
2 Family emerge
1 Fractured foot 
2 lost to post-assessment
1 Family emergency
1 Other diagnosis (Flu)
25 completed Week 12
(Post-assessment)
26 completed 
(Post-asses
6 Lost to Mid assessment
2 Change in work schedules  
2 Non-compliance 
1 Family emergency
1 Breast Cancer
4 Lost to Mid ass
1 Felt Yoga sessi
Difficult 
1 Non-complian
1 Moved; 1 Surg
Combination g
n = 33
(Week 0, Pre-a
Yoga group (YG)
n = 33
(Week 0, Pre-assessment)
Began Yoga Intervention
Assessed for e
n = 12
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n = 97
Fig. 1. Flowchart of patients—rabetween the extended middle ﬁngers of both hands was measured
and recorded to the nearest cm for the right shoulder. The same
procedure was followed for the left shoulder.
[327_TD$DIFF] .11.4. Deﬁnition of a responder
Responders were identiﬁed for the two primary endpoints.
(i) IBS-SSS: a responder was deﬁned as patient whose overall
symptom severity on the IBS-SSS improved 50 points from
baseline toWeek 6 andWeek 12 [40] and (ii) IBS-QOL: a responder
was deﬁned as patient whose quality of life had a meaningful
change of 14 points, from baseline to Week 6 and Week 12 [41].
[328_TD$DIFF] .12. Data analysis and statistics
The primary end points were between group differences in the
changes of IBS-SSS and IBS-QOL scores from week 0 compared to
week 6 andweek 12 visits. The secondary end pointswere to assess
whether changes in HADS, Autonomic Symptom Scores, IBS-GAI,
Medicine and Supplement use, BMI, physical ﬂexibility, and
autonomic function tests differed between the groups. Week 6
ment)
27 completed Week 6
(Mid assessment)
0 lost to post-assessmentssment
ncies
at home 
Week 12
sment)
27 completed Week 12
(Post-assessment)
essment
on was 
ce
ery
4 Lost to Mid assessment
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roup (CG)
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Maintain life style
23 subjects not included
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6 Time conflict with Yoga 
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0
ized 
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allocation and not directly involved in the research.
Within-group comparisons were also performed for explorato-
ry reasons. A per-protocol analysis of data obtained from patients
completing the study was performed. Also, an intention-to-treat
analysis, that included all randomized patients, was carried out.
Statistical analysis was carried out using SPSS (Scientiﬁc
Packages for Social Sciences, IBM Corporation, NY, version 20.0).
Initial tests of normality showed therewere no baseline differences
between groups on demographic and clinical variables, such as age,
weight, and duration of IBS. The baseline data of all the
assessments were tested for normality and all data were normal.
Repeated measures Analyses of Variance (ANOVAs) were per-
formed for each assessment with 2 factors[284_TD$DIFF]: (1). Groups: Yoga
group, Combination group and Control group; and (2) Time points:
Week 0 (pre-intervention), Week 6 (mid-intervention) and Week
12 (post-intervention). Repeated measures ANOVAs were carried
out separately followed by post hoc analyses with Bonferroni
correction, for all the primary and secondary end points, for
multiple comparisons between the mean values of different Time
points. All comparisons were made with respective Week 0 (pre-
intervention) values. McNemar’s test and t-test were used to
analyze the nominal data of Medicine and Supplement Use, and
responders. For “Intention To Treat” (ITT) analysis, missing values
were analyzed with multiple imputation method.
3. Results
3.1. Subjects
A total of 97 IBS patients fulﬁlled the inclusion and exclusion
criteria and were randomized into the trial. Overall, 8 patients inTable 3
Characteristics of 78 total subjects that completed the study.
Total (78) Yoga group (25)
Marital status
Married/cohabitant 44 (56.4%) 17 (68.0%)
Single 26 (33.3%) 6 (24.0%)
Divorced 7 (9.0%) 1 (4.0%)
Widowed 1 (1.3%) 1 (4.0%)
Ethnicity
Hispanic 56 (71.8%) 15 (60.0%)
Non-hispanic 22 (28.2%) 10 (40.0%)
Education
Middle school 4 (5.1%) 2 (8.0%)
High School 33 (42.3%) 5 (20.0%)
College 41 (52.6%) 18 (72.0%)
Employment
Full-time 51 (65.4%) 19 (76.0%)
Part-time 15 (19.2%) 1 (4.0%)
Home-maker 3 (3.9%) 1 (4.0%)
Unemployed 4 (5.1%) 2 (8.0%)
Retired 5 (6.4%) 2 (8.0%)
Economic status
<30k 39 (50.0%) 9 (36.0%)
30–60k 26 (33.3%) 10 (40.0%)
60–100k 9 (11.6%) 5 (20.0%)
>100k 4 (5.1%) 1 (4.0%)
IBS subgroups
IBS—constipation 28 (35.9%) 8 (32.0%)
IBS—diarrhea 23 (29.5%) 10 (40.0%)
IBS—mixed 27 (34.6%) 7 (28.0%)
Percent in parentheses represents value of the total in a given category.the Yoga and 7 patients in the Combination groups discontinued
the study, either due to family emergencies (4 patients), other
conditions (4 patients) or time conﬂicts (3 patients). There were 3
non-compliant patients [285_TD$DIFF]who were excluded from the analysis and
not from the study. There were 4 dropouts in the Wait-list Control
group, 3 were lost to follow-up, and one [286_TD$DIFF]died. Fig. 1 shows the ﬂow
of subjects from [329_TD$DIFF]randomization to completion.
A total of 78 patients, of the 97 enrolled, completed the study
andwere included in the per-protocol analysis. Subjects comprised
of IBS-C (n =28, median age 43 years; 35.9% of total completed),
IBS-D (n =23, median age 45 years; 29.5% of total completed), and
IBS-M (n =27, median age 45 years; 34.6% of total completed). The
median duration of IBS from diagnosis before enrolling into the
trial was ﬁve years andmedications usedwere two years. Details of
the demographic data are shown in Table 3.
3.2. Yoga practice
It was required that both Yoga and Combination groups attend
at least 75% (27 out of 36) of the Yoga sessions, and on an average,
the subjects attended 33 classes in 12 weeks, about 90%
attendance.
3.3. Per-protocol analysis
Repeated measures ANOVA were performed for each assess-
ment with two factors: Time points (Week 0,Week 6 andWeek 12)
and groups. Signiﬁcantmain effects of time points and groups; and
the interaction between time points, groups and assessments are
given in Supplement Table 1.Combination group (26) Wait[249_TD$DIFF]-list (Control) group (27)
12 (46.2%) 15 (55.6%)
11 (42.3%) 9 (33.3%)
3 (11.5%) 3 (11.1%)
0 0
19 (73.1%) 22 (81.5%)
7 (26.9%) 5 (18.5%)
1 (3.9%) 1 (3.7%)
11 (42.3%) 17 (63.0%)
14 (53.8%) 9 (33.3%)
14 (53.9%) 18 (66.7%)
8 (30.8%) 6 (22.2%)
1 (3.8%) 1 (3.7%)
1 (3.8%) 1 (3.7%)
2 (7.7%) 1 (3.7%)
15 (57.7%) 15 (55.6%)
8 (30.8%) 8 (29.6%)
2 (7.7%) 2 (7.4%)
1 (3.8%) 2 (7.4%)
10 (38.5%) 10 (37.0%)
6 (23.0%) 7 (26.0%)
10 (38.5%) 10 (37.0%)
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Fig. 2. Changes in IBS-SSS in IBS patients enrolled in the randomized controlled trial of Yoga Therapy. Comparison of IBS-SSS atWeek 6 (Mid-intervention) andWeek 12 (Post-
intervention) to Week 0 (Pre-intervention). Data were analyzed using Repeated Measures of ANOVA followed by Post hoc analysis with Bonferroni [306_TD$DIFF]correction. *: Represents
mean change Within groups when compared to Week 0; ***p<0.001; x: Represents Between group differences when compared to Control group; xxxp<0.001.
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Post hoc analysiswith Bonferroni correction of IBS—SSS showed
a signiﬁcant improvement in Yoga and Combination groups when
compared to Control group. Fig. 2 illustrates the changes between
groups and time points. Therewas a signiﬁcant difference between
Yoga and Control groups atWeek 6 (p<0.001), and atWeek 12, the
mean difference was 226.3116.8; [185.17, 267.44], (p<0.001).
There was a signiﬁcant difference between Combination and
Control groups at Week 6 (p<0.001) and at Week 12, the mean
difference was 189.7216.63 [149.01, 230.44], (p<0.001). There
were no signiﬁcant differences between Yoga and Combination
groups.
The ﬁve sub-scales of IBS-SSS were analyzed in detail (Fig. 3).
Signiﬁcant improvements were observed in all ﬁve categories in
Yoga (p<0.001) and Combination groups (p<0.001) when
compared to [287_TD$DIFF]the Wait-list Control group. Within group changes
of Yoga and Combination showed signiﬁcant improvements at
Week 6 (p<0.001) and at Week 12 (p<0.001) when compared to
Week 0.
3.5. IBS-QOL
Fig. 4 illustrates the changes between groups and time points.
There was a signiﬁcant difference between Yoga and [251_TD$DIFF]Wait-list
Control group at Week 6 (p<0.001), and at week 12, the mean
difference was 56.535.71 [42.56, 70.5]; (p<0.001). Similarly, a
signiﬁcant difference between Combination and Control group at
Week 6 (p<0.001) as well as at Week 12, the mean difference was
47.955.65 [34.12, 61.77]; (p<0.001), was observed.
A similar detailed analysis of eight dimensions of IBS—Quality
of Life assessments was carried out. As shown in Fig. 5, there was a
signiﬁcant difference between Yoga and [297_TD$DIFF]Wait-list Control group
(p<0.001) and Combination and [330_TD$DIFF]the Wait-list Control group
(p<0.001) in all eight dimensions. Within group changes were
observed in dimensions of one to six and eight in Yoga and
Combination groups at Week 6 (p <0.001) and at Week 12
(p<0.001) when compared to Week 0.3.6. Secondary outcome assessments—Hospital Anxiety and
Depression [310_TD$DIFF]Scale (HADS), Autonomic Symptom Score, and IBS-global
assessments of improvement (IBS-GAI)
Fig. 6 depicts the comparison of all these assessments, between
group differences and within group changes fromWeek 0 toWeek
6 andWeek 12. There were signiﬁcant improvements in both Yoga
and Combination groups in HADS and IBS-GAI assessments when
compared to Control group, at Week 6 (p<0.001) and at Week 12
(p<0.001). In the assessment of [289_TD$DIFF]the Autonomic Symptom Score, a
signiﬁcant difference between Yoga and Control groups (p<0.01);
Combination and Control groups (p<0.05) at Week 12 was
observed.
3.7. Medicine and supplement use
At the baseline appraisal, Medication/Supplements for relieving
IBS symptoms were used by 19 out of the 25 subjects in the Yoga
group, 21 out of the 26 in the Combination group and 22 out of the
27 in the Control group. Therewere a total of 16 subjects (6 in Yoga [290_TD$DIFF],
5 in Combination and 5 in Control group) that did not use any
medication/supplements. Most commonly used medication/sup-
plements (by all the groups) were Dicyclomine, Bentyl, amitiza,
Linzess, Loperamide, psyllium, ﬁber drinks, herbal teas and
probiotics. Medicine and Supplement usage reported during Week
6 assessment decreased signiﬁcantly in the Yoga and Combination
groups compared to the Control group (p<0.001). Upon comple-
tion of the intervention of 12 weeks, signiﬁcant differences
between groups (p<0.001) continued and almost all of the Yoga
and Combination group subjects reported either stopping or
reducing the medications. There were no signiﬁcant differences
between Yoga and Combination groups (Table 4).
4. Measurements
4.1. BMI and physical ﬂexibility
There were no changes observed in the Body Mass Index
(Supplement Fig. 2A) in any of the groups. Between group analyses
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Fig. 3. Changes in ﬁve sub-scales of IBS-SS in IBS patients enrolled in the randomized controlled trial of Yoga Therapy. (A) Pain Severity, (B)Duration of Pain, (C)Abdominal
distension, (D)Bowel Satisfaction and (E) Interference with life at Week 6 (Mid-intervention) and Week 12 (Post-intervention) from Week 0 (Pre-intervention). Data were
analyzed using RepeatedMeasures of ANOVA followed by Post hoc analysis with Bonferroni [306_TD$DIFF]correction. *: Representsmean changeWithin groupswhen compared toWeek 0;
***p<0.001; x: Represents Between group differences when compared to Control group; xxp<0.01; xxxp<0.001.
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physical ﬂexibility. There was a signiﬁcant difference between
Yoga and [251_TD$DIFF]Wait-list Control groups in the hip-trunk ﬂexibility,
(p<0.001), right (p<0.05) and left shoulder ﬂexibility (p<0.05) at
Week 12. When Combination and [251_TD$DIFF]Wait-list Control groups were
compared, therewere signiﬁcant differences in the trunk ﬂexibility
(p<0.001), right (p<0.01), and left shoulder ﬂexibility (p<0.05),at Week 12. Hip-trunk ﬂexibility (Supplement Fig. 2B), [292_TD$DIFF]and right
and left shoulder ﬂexibility showed signiﬁcant improvements in
the Yoga and Combination groups at Week 6 and at Week 12
(p<0.001) when compared to Week 0 (Supplement Fig. 2C1 and
C2). There were no improvements in the physical ﬂexibility of the [293_TD$DIFF]
Wait-list Control group.
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Fig. 4. Changes in IBS-QOL in IBS patients enrolled in the randomized controlled trial of Yoga Therapy. Comparison of IBS-QOL at Week 6 (Mid-intervention) and Week 12
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5.1. Sympathetic reactivity tasks
In the sympathetic reactivity [331_TD$DIFF]tasks, there were no changes
within the group or between the groups in the diastolic blood
pressure (measured in handgrip task), heart rate and blood
pressure (measured inmental arithmetic task). However, handgrip
strength increased signiﬁcantly within Yoga and Combination
groups atWeek 12 (p<0.001)when compared toWeek 0, but there
were no signiﬁcant differences observed between the three groups
(Supplement Fig. 3A).
Signiﬁcant improvements in speed (measured by number of
attempted responses) and accuracy (measured by number of
correct responses)were observed atWeek 12 in Yoga (p<0.05) and
in Combination groups (p<0.001). There were no differences
observed between groups (Supplement Fig. 3B).
5.2. Parasympathetic reactivity tasks
In the parasympathetic reactivity [332_TD$DIFF]task of deep breathing,
(Supplement Fig. 4 A1–A4), there were no changes or differences
within or between groups in the time domain of heart rate
variability of deep breathing. In the frequency domain of heart rate
variability, there was no difference between Yoga and [297_TD$DIFF]Wait-list
Control groups, but there were signiﬁcant differences between
Combination and [251_TD$DIFF]Wait-list Control groups at Week 12, in LF
(p<0.05), HF (p<0.01) and LF/HF ratio (p<0.01). Combination
group showed decreased LF (p<0.001), increased HF (p<0.001)
and [333_TD$DIFF]increased LF/HF ratio (p<0.01) at Week 12 when compared to
Week 0.
In the supine to upright posture (30–15 ratio), there were no
differences between the three groups at the end of intervention.
Therewere no changeswithin Combination groupwhen compared
to Week 0. However, in the Yoga group, there were signiﬁcant
improvements in the parasympathetic dominance at Week 6
(p<0.01) and at Week 12 (p<0.01) when compared to Week 0
(Supplement Fig. 4B).[334_TD$DIFF]6. Intention-to-treat analysis
All randomized patients (97, Yoga =33; Combination= 33; [296_TD$DIFF]Wait-
list Control = 31) were included in this analysis. There were 19
dropouts who attended the baseline measurements and 5 of them
also attended the mid-intervention (Week 6) appraisal. The
missing data were analyzed with multiple imputation method.
The values below represent pooledmeans S.D. [min,max values].
The signiﬁcant changes found in per-protocol analysis were also
found in the intention-to-treat analysis. There was a signiﬁcant
difference in the improvement in the IBS-SS score between Yoga
and [297_TD$DIFF]Wait-list Control group at Week 6 (p<0.001) and at Week 12
(p<0.001); and Combination and [251_TD$DIFF]Wait-list Control groups (p
<0.001) at both time points. There were no differences between
Yoga group and Combination group (p =Not Signiﬁcant). The Yoga
group changed from 321.7362.71 [181, [335_TD$DIFF]445] at Week 0, to
81.2351.89 [0,199] at Week 12 (p<0.001). The Combination
group changed from 334.2772.63 [202, [336_TD$DIFF]485] at Week 0 to
111.7865.15 [0, 277] at Week 12 (p<0.001). Control group
changed from 303.8170.87 [171, 433] at Week 0 to
305.6458.91 [177, 430] at Week 12 (p =Not signiﬁcant). There
was a signiﬁcant difference between Intervention groups and
Control group at both time points of mid-intervention and post-
intervention (p<0.001) in the quality of life assessment. Quality of
Life improved in Yoga group from98.0626.94 [44, [337_TD$DIFF]149] atWeek 0
to 154.8111.65 [117, [338_TD$DIFF]170] at Week 12 (p<0.001). Combination
group showed an increased QOL from 95.8228.91 [339_TD$DIFF] 44,149] at
Week 0 to 146.3220.36 [95, 170] [340_TD$DIFF]at Week 12 (p<0.001). In
contrast, Control group did not improve, it changed from
98.3525.41 [53, 154] [341_TD$DIFF]at Week 0 to 98.5524.09 [42, 149] [342_TD$DIFF]at
Week 12 (p =Not Signiﬁcant). Similar trends of between group
differences were observed in all the assessments. In autonomic
function tasks, there were no differences observed between [343_TD$DIFF]the
Yoga, Combination and [344_TD$DIFF]Wait-list Control groups.
6.1. Responder analysis
78 patients were included in the responder analysis. In the
assessment of IBS-SSS, 65% were responders (50 point improve-
ment) at Week 6, and 73% at Week 12. The intervention groups
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Fig. 5. Changes in eight dimensions of IBS-QOL in IBS patients enrolled in the randomized controlled trial of Yoga Therapy. (A) Dysphoria, (B) [307_TD$DIFF] nterference with Activity, (C)
Body Image, (D) [308_TD$DIFF]Health Worry, (E) Food Avoidance, (F) Sexual Relations, (G) Social Reaction, and (H) Relationships at Week 6 (Mid-intervention) and Week 12 (Post-
intervention) fromWeek 0 (Pre-intervention). Datawere analyzed using RepeatedMeasures of ANOVA followed by Post hoc analysiswith Bonferroni [306_TD$DIFF]correction. *: Represents
mean change within groups when compared to Week 0; **p<0.01; ***p<0.001; x: Represents Between group differences when compared to Control group; xp<0.05;
xxp<0.01; xxxp<0.001.
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Fig. 6. Changes in secondary assessments in IBS patients enrolled in the randomized controlled trial of Yoga Therapy. (A) HADS (anxiety and depression); (B)Autonomic
Symptom Score; and (C) IBS-GAI at Week 6 (Mid-intervention) and Week 12 (Post-intervention) from Week 0 (Pre-intervention). Data were analyzed using Repeated
Measures of ANOVA followed by Post hoc analysis with Bonferroni [306_TD$DIFF]correction. *: Represents mean change Within groups when compared to Week 0; ***p<0.001; x:
Represents between group differences when compared to Control group; xp<0.05; xxp<0.01; xxxp<0.001.
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Table 4
Comparison of changes in IBS Medication and Supplement Usage in the Yoga, Combination and Control groups at Week 6 and Week 12 assessments.
Assessment Outcome Groups P-Value
Yoga Combination [250_TD$DIFF]Wait-list Control
Week 6
(mid-intervention)
Success 19 20 4 *** xxx
Failure 0 1 18
No medication used 6 5 5
Week 12
(post-intervention)
Success 19 20 7 *** xxx
Failure 0 1 15
No medication used 6 5 5
Success—stopped or decreased medication use; failure—no change or increased medication use; no medication used: was not using any medication at baseline.
Data were analyzed using McNemar’s test.
*: Represents signiﬁcant differences between Yoga and Control groups; ***p<0.001; x: represents signiﬁcant differences between Combination and [251_TD$DIFF]Wait-list Control groups;
xxxp<0.001.
606 V. Kavuri et al. / European Journal of Integrative Medicine 7 (2015) 595–608(n=51) had 94% responders at Week 6 and 100% at Week 12. The
Wait-list Control group had 22% responders atWeek 6 and atWeek
12. Baseline IBS-SSS score for all patients was (317.7570.29).
There was a signiﬁcant improvement in the responders of IBS-SSS
from Week 6 (175.2275.38), to Week 12 (117.8282.82;
p<0.001). There were no changes observed in non-responders
at the two time points.
In IBS-QOL, 47% were responders (14% improvement) at Week
6, and 64% at Week 12. The intervention groups (n =51) had 64%
responders at Week 6, and 92% at Week 12. The Wait-list Control
group had 15% and 11% responders at Week 6 and Week 12,
respectively. Baseline IBS-QOL score for all patients was
(98.6828.08). A signiﬁcant change was observed in the quality
of life of responders from Week 6 (134.2719.25) to Week 12
(149.0218.74; p<0.001). There were no changes observed in the
non-responders at both time points.
[345_TD$DIFF]6.2. Adverse events
Participants were encouraged to contact study investigators/
staff regarding any potential problems/concerns. Three patients,
two in Yoga group and one in Combination group had complained
of low back pain that was aggravated. The instructors took special
care in monitoring and suggesting certain modiﬁed practices for
these three patients. All of them reported being relieved of back
pain within a week and completed the program. These complaints
were not recorded as adverse events. There were other reported
adverse events such as ﬂu, cataract surgery, and other diagnoses,
which prompted the patients to discontinue the study. These
events were self-limited and deemed by the investigators and the
data safety monitoring board to not be serious. Death of aWait[300_TD$DIFF]-list
control group patient was also reported, 4 weeks after his baseline
measurements, due to massive cardiac arrest and happened at
home while in sleep.
[346_TD$DIFF]7. Discussion
In the present study, a 12 week intervention of RYM showed
signiﬁcant decreases in the severity of IBS symptoms, improved [347_TD$DIFF]
QOL, and lowered Anxiety, Depression, and Autonomic symptom
scores in both Yoga and Combination groups. Also, signiﬁcant
improvements were observed in physical ﬂexibility and Medicine
and Supplement Use in the intervention groupswhen compared to
Wait-list Control group (results of the RYM intervention for the
Wait-list Control group are reported in Phase 2, page—this issue).
There was a reduction in the sympathetic dominance in the
Combination group when compared to Yoga and Control groups.
Similarly, changes in all of the ﬁve IBS-SS sub-scales and eight
dimensions of QOL were observed at Week 6 and improvements
continued at Week 12 suggesting that all components of RYM—postures, regulated breathing, and meditation are a superior
alternative than just meditation [26–28] or postures alone [22,23].
It is recommended that adults engage inmoderate physical activity
of 20–60min a day for 3–5 days of the week, to promote/maintain
health [42,43]. Usual range of dropouts in any physical exercise
intervention trials is 25–50% and adherence rates of about 66%
[44]. RYM with about 22% attrition (24% in Yoga and 21% in
Combination groups [301_TD$DIFF]) mainly owing to time constraints and family
issues and adherence of about 90% could be proposed as an
effective intervention.
Our results of IBI-GAI and bowel symptom score are parallel to
an earlier report involving another Yoga strategy on adolescents
and young adults [24]. The autonomic symptom score is
signiﬁcantly improved than that reported in another Yoga study
carried out on IBS adult male patients [25]. When compared to
earlier reports on Meditation for IBS (that measured IBS-SSS, IBS-
QOL, HADS), RYM intervention exhibited signiﬁcant improvements
in all three assessments at Week 6 that continued to the end of
study period [26,27].
Our study concurs with the conclusion of a review by Ross and
Thomas, that Yoga may be as effective as or better than exercise in
improving a variety of health related outcome measures [45].
Johannesson and co-workers investigated 12 weeks of physical
activity as an intervention for IBS patients, and reported a
reduction of 51 points in IBS-SSS, signiﬁcant improvements in a
few dimensions of IBS-QOL, and no improvement in HADS and BMI
[43]. Results of our study were signiﬁcantly higher (120 point
reduction in IBS-SSS; a 23% increase in IBS-QOL) in all of the above
assessments, except for BMI which was not impacted by 12 weeks
of RYM. In the present study, about 60% of the patients in both Yoga
and Combination groups have reported of either no headaches
(part of autonomic symptom score) or less frequent and less severe
episodes which are in line with the observation by John et al. [46].
The results of lowered/[302_TD$DIFF]cessation of Medication and Supplement
Use by Yoga and Combination groups, are in concurrence with a
report of Yoga for treatment of low back pain [36].
The signiﬁcant improvements observed in the handgrip
strength of the present study are comparable to another study
[47]. In the mental arithmetic task, both Yoga and Combination
groups had elevated levels of speed and accuracy, and are
consistent with the results of an investigation by Field et al.
[48]. In a 15-week Yoga study, Hagins et al. found that the heart
rate and blood pressure are unchanged during the mental
arithmetic task, and our study observed similar statistically
non-signiﬁcant trend [49].
Several studies have concluded that there is an autonomic
imbalance toward sympathetic dominance and vagal withdrawal
in IBS patients [9,50,51]. In the present study, the parasympathetic
dominance increased, during deep breathing (Combination group)
and the orthostatic test of 30:15 (Yoga group), suggesting that Yoga
V. Kavuri et al. / European Journal of Integrative Medicine 7 (2015) 595–608 607intervention could have improved the autonomic imbalance in IBS
patients.
Three groups and three measurements were designed in this
randomized trial to distinguish between different intervention
groups and [297_TD$DIFF]Wait-list Control group; and optimal duration of
intervention. In the subjective assessments, Yoga group fared
better than Combination group. In the objective assessments, both
Yoga and Combination groups showed increased parasympathetic
tone. The results observed at Week 6 of RYM intervention, showed
favorable changes in all symptoms associated with IBS, but the
autonomic system changes were observedmostly at Week 12. This
could imply that 12 weeks of RYM, three times a week, would be
optimal intervention duration for IBS. The subjects in the [293_TD$DIFF]Wait-list
Control group showed no changes in any of the primary or
secondary variables from Week 0 to Week 12.
Our study presented the ﬁrst one hour RYM as a treatment
modality for IBS in adults that included both genders and all
subgroups of IBS, with predominant women IBS sufferers. The
patients reported improvements in their IBS condition, and
developed group support in the Yoga sessions. Almost all patients
reiterated that the Yoga program was highly enjoyable and
beneﬁted their lives. About 80% of the patients self-reported that
they had better energy levels, and better sleep, associating with
Yoga sessions (Supplement Table 2).
Limitations of the present study include the inability of blinding
the subjects which was not possible due to the nature of the
intervention, and [348_TD$DIFF]the lack of an active control group. With
adequate funding, gastric motility tests could be undertaken. IBS
subgroups (IBS-C, D or M) were not assessed separately as the
numbers were too small in each group. Future studies could
investigate the beneﬁts of RYM on each subgroup of IBS separately.
Due to inherent challenge with adherence to special dietary
guidelines (especially in the expected majority of study partic-
ipants), we did not emphasize [349_TD$DIFF]diet. However, a combination of
RYM and diet; with a detailed Medicine and Supplement Use and
the safety of RYMwhen compared to other intervention also could
be explored. Large multicenter clinical trials may be conducted in
future to explore the beneﬁts of RYM in IBS sufferers from various
social backgrounds.
In conclusion, RYM could be a valuable, effective and a viable
treatment option for IBS. With RYM intervention, both Yoga and
Combination groups have shown similar improvements in all of
the assessments. It is worth noting that Combination group had
voluntarily reduced their Medicine and Supplement Use. A Yoga
module with precise number of rounds and duration of each
practice was presented. We believe the given module would allow
other researchers to replicate the study. The group setting could
have facilitated group dynamics and support amongst the patients
motivating them to adhere to the program (90% attendance). RYM
was found to be a safe intervention without any major adverse
events associated with the intervention. The overall outcome of
this study suggests that supervised Yoga sessions could be a better
option to motivate the participants, as well as to monitor the
patients and prevent any injuries. RYM could be recommended to
IBS sufferers without prior exposure to Yoga, since our sample size
consisted largely of Hispanic population who were naïve to Yoga.
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